6533b861fe1ef96bd12c59d6

RESEARCH PRODUCT

Detection of increased tyrosine phosphorylation in murine Langerhans cells after stimulation with contact sensitizers.

Ulrich NeisiusPia BrandJoachim SalogaJürgen KnopSibylle PlochmannDetlef Becker

subject

MaleLangerhans cellBlotting WesternDermatologyPicryl ChlorideBiologyCell Linechemistry.chemical_compoundMicemedicineAnimalsTyrosinePhosphorylationPhosphotyrosineMice Inbred BALB CTyrosine phosphorylationGeneral MedicineDendritic cellFlow CytometryMolecular biologyIn vitromedicine.anatomical_structureBiochemistrychemistryLangerhans CellsPhosphorylationTyrosineFemaleTyrphostin A9Signal transductionSignal Transduction

description

The signalling pathways in epidermal Langerhans cells (LC) during activation by contact sensitizers are poorly understood. Recently, we have described an increased phosphorylation of tyrosine residues in human MHC class II-positive cells in vitro following stimulation with contact sensitizers. In the study reported here the formation of phosphotyrosine (p-tyr) in murine epidermal LC upon stimulation with contact sensitizers was examined. By the use of a flow cytometric technique a significant increase in p-tyr was demonstrated in LC stimulated in vitro with the strong contact sensitizers TNCB (2,4,6-trinitro-chlorobenzene) and MCI/MI (5-chloro-2-methylisothiazolinone plus 2-methylisothiazolinone) but not after treatment with the irritants sodium lauryl sulphate or benzoic acid. The protein tyrosine kinase inhibitors genistein and tyrphostin A9, but not tyrphostin AG 1288, were able to block this process significantly. Similar results were obtained using the LC-like dendritic cell line XS52. In addition, Western blot analysis on XS52 cells revealed a selective phosphorylation of two protein bands with a molecular weight between 50 and 60 kDa following stimulation with TNCB. These results demonstrate that contact sensitizers induce an increased phosphorylation of tyrosine residues in murine LC and can be used as the basis for in vivo studies using inhibitors for signal transduction pathways for prevention of primary sensitization to contact sensitizers.

10.1007/s004030050379https://pubmed.ncbi.nlm.nih.gov/10025724